10th International Conference on Cancer Stem Cells and Regenerative Medicine

Cancer Stem Cells: Targeting the Roots of Cancer Allied academies medical meetings Allied Academics welcomes you to attend the 10th International Conference on Cancer Stem Cells and Regenerative Medicine, during June 29-30, 2017 in London, UK. We cordially invite all the participants who are interested in sharing their knowledge and research in the arena of Cancer Stem Cells and its applications with the theme " Cancer Stem Cells: Targeting the Roots of Cancer." Cancer stem cells (CSCs) are cancer cells (found within tumors or haematological cancers) that possess characteristics associated with normal stem cells, specifically the ability to give rise to all cell types found in a particular cancer sample. CSCs are therefore tumorigenic (tumour-forming), perhaps in contrast to other non-tumorigenic cancer cells. CSCs may generate tumors through the stem cell processes of self-renewal and differentiation into multiple cell types. Such cells are hypothesized to persist in tumors as a distinct population and cause relapse and metastasis by giving rise to new tumors. Therefore, development of specific therapies targeted at CSCs holds hope for improvement of survival and quality of life of cancer patients, especially for patients with metastatic disease. Global Market Study of Cancer Stem Cells and Regenerative Medicine: USA: According to a report published by W.H.O cancer fatalities are expected to increase from 14 million in 2012 to 22 million in 2020, 8.2 million deaths worldwide were due to cancer, colorectal cancer constituted 8.4%, breast cancer constituted 6.0% and liver constituted 9.0% in 2012. Europe: Global Cancer stem cell market is expected to grow at a CAGR of 23% for the forecasted period of 2015-2020. Cancer Stem cell research is also being used to study genetic disorders, birth defects and other growth factors. Middle East: Cancer Stem Cell Therapy was conditionally approved in Canada in 2012 .Mesenchymal Stem Cells are purified from the marrow, cultured and packaged, with up to 10,000 doses derived from a single donor. The doses are stored frozen until needed. Asia Pacific: According to a new market research report, ‘Global Cancer Stem Cell Market – Growth, Trends & Forecasts (2015-2020)’, published by Mordor Intelligence, the Global market is expected to be worth US$ 30.25 billion by the end of 2020, The Global market for Stem Cells is expected to grow at a CAGR of 13.7% during the period of (2015-2020). Anyone interested in the future of emerging Oncology techniques majorly in Cancer Stem Cells 2017 to attend, Connect with our social network pages to get regular industry updates. About Allied academies: Allied academies own and operate several academic journals and conferences. Since its establishment 1995, Allied Academies promotes peer reviewed healthcare information through meetings, scholarly journals, and training to leading academic, business and research institutes across the healthcare and life science industries. Program Coordinator Liza Smith Allied Academies, P.O. Box 670, Candler, NC 28715, USA, Email:cancerstemcells@alliedconferences.org www.alliedacademies.org